The right to own research drives medtech innovation in Sweden
This article was originally published in Clinica
Sweden’s Stockholm-Uppsala region is ranked as Europe’s third largest life sciences cluster and is home to many established medtech companies, such as Biovitrum, Maquet, Elekta and Phadia. However, the two cities also play host to the next generation of medtech firms. Joseph Harvey visited the region to find out how a specific law is aiding medtech growth there
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals